|
CAMLG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.11429999999557E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.82719999999903E-05 |
| Normal-vs-Stage2 |
1.502390E-02 |
| Normal-vs-Stage3 |
1.010030E-04 |
| Normal-vs-Stage4 |
1.784890E-04 |
| Stage1-vs-Stage2 |
9.544200E-01 |
| Stage1-vs-Stage3 |
6.605400E-01 |
| Stage1-vs-Stage4 |
1.633560E-01 |
| Stage2-vs-Stage3 |
8.258400E-01 |
| Stage2-vs-Stage4 |
3.400200E-01 |
| Stage3-vs-Stage4 |
2.971000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46649999999793E-05 |
| Normal-vs-AfricanAmerican |
4.842000E-04 |
| Normal-vs-Asian |
1.222210E-04 |
| Caucasian-vs-AfricanAmerican |
4.102600E-01 |
| Caucasian-vs-Asian |
4.571400E-01 |
| AfricanAmerican-vs-Asian |
7.810400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.555490E-04 |
| Normal-vs-Female |
1.60510999999142E-05 |
| Male-vs-Female |
8.662600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.55230000000418E-05 |
| Normal-vs-Age(41-60Yrs) |
1.58824999999529E-05 |
| Normal-vs-Age(61-80Yrs) |
2.423400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.122200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.862000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.000400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.156800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.581600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.145400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.144600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.708200E-01 |
| Classical-VS-Follicular |
2.44189999999422E-05 |
| Classical-VS-Other |
5.625200E-01 |
| Classical-VS-Normal |
5.32289999854996E-08 |
| Tall-VS-Follicular |
8.242900E-03 |
| Tall-VS-Other |
6.312800E-01 |
| Tall-VS-Normal |
3.556500E-04 |
| Follicular-VS-Other |
7.589500E-02 |
| Follicular-VS-Normal |
4.015800E-01 |
| Other-VS-Normal |
1.102750E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.798430E-04 |
| Normal-vs-N1 |
3.618400E-02 |
| N0-vs-N1 |
4.850000E-01 |
|
|
